First company to go public on the NYSE MKT under JOBS Act Regulation A+
Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage
medical robotics company, today announced the completion of its initial public offering (IPO)
under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares of its
common stock at a price to the public of $7.50 per share. The Company also closed on a
simultaneous private sale of investment units comprised of restricted securities to accredited
investors, majority of whom are early investors in Myomo, for total proceeds of $2.9 Million.
The combined capital raised is $7.9 Million. Read more…